Nutribiotech Australia Pty. Ltd. announced that it has received AUD 10 million in funding from Cosmax Nbt, Inc.
Nutribiotech Australia Pty. Ltd. announced that it has issued 10,000,000 common shares at a price of AUD 1 per share for gross proceeds of AUD 10,000,000 on May 10, 2019. The transaction involved participation from returning investor Cosmax Nbt, Inc. (KOSDAQ:A222040). The investor continues to retain 100% stake in the company. Prior to the transaction, the company had a capital of KRW 8,754,400,000 (AUD 10,659,198.83) with a total of 10,000,000 issued common shares. Post the transaction, the company has issued a total of 20,000,000 common shares. The transaction has been approved by the board of directors of the investor.